Quantitative structure-activity relationships for a series of selective estrogen receptor-beta modulators (Q46882322)

26 December 2017

title

Quantitative structure-activity relationships for a series of selective estrogen receptor-beta modulators (English)

1 reference

26 December 2017

author name string

Salum LB

series ordinal

1

1 reference

26 December 2017

Polikarpov I

series ordinal

2

1 reference

26 December 2017

Andricopulo AD

series ordinal

3

1 reference

26 December 2017

publication date

1 October 2007

1 reference

26 December 2017

SAR and QSAR in Environmental Research

published in

1 reference

26 December 2017

volume

18

1 reference

26 December 2017

page(s)

711-727

1 reference

26 December 2017

issue

7-8

1 reference

26 December 2017

Production and actions of estrogens

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Biological role of estrogen and estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Sequence and expression of human estrogen receptor complementary DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

ER beta: identification and characterization of a novel human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Principles for modulation of the nuclear receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Osteoporosis: prevention with estrogens in women over 60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Hormones, mood, and cognitive functioning in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure-a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Perspectives in hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Menopausal symptoms in older women and the effects of treatment with hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Hormone replacement therapy and cancer risk: A systematic analysis from a network of case‐control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Hormone replacement therapy and endometrial, ovarian and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

The menopause, hormone replacement therapy and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Postmenopausal hormone replacement therapy: endometrial and breast effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Pitfalls of the WHIs: Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Clinical significance of estrogen receptor beta in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

ERbeta: a novel estrogen receptor offers the potential for new drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Phyto-oestrogens and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Phytoestrogens, cancer and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Structure-activity relationships for a collection of structurally diverse inhibitors of purine nucleoside phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10629360701698811

10.1080/10629360701698811

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

18038369

1 reference

26 December 2017